MRI Interventions Announces Participation in Fall Medical Conferences
IRVINE, Calif., Oct. 8, 2014 (GLOBE NEWSWIRE) -- MRI Interventions, Inc. (OTCQB:MRIC) today announced its participation as an exhibitor at two major medical conferences this Fall.
From October 10-11, 2014, the company will exhibit its ClearPoint® and ClearTrace® systems at the 2014 Interventional MRI Symposium in Leipzig, Germany. The ClearPoint system, which has received FDA 510(k)-clearance and is CE-marked, is the only navigation platform on the market to enable real-time MRI-guided visualization during minimally invasive procedures in the brain. The ClearTrace system, currently in development in partnership with Siemens Healthcare, is designed to enable real-time MRI guidance for minimally invasive procedures in the heart.
From October 20-22, 2014, MRI Interventions will exhibit its ClearPoint system at the Congress of Neurological Surgeons 2014 Annual Meeting in Boston, Massachusetts. CNS attendees are invited to visit Booth #242 on the exhibit floor to learn more about the ClearPoint navigation platform for real-time MRI-guided neurosurgery. Company representatives will be onsite to discuss and display recent ClearPoint software updates, the new SmartTwist® hand drill for minimally invasive twist drill access, and the new Scalp-Mount SmartFrame® trajectory device.
About MRI Interventions, Inc.
Building on the imaging power of MRI, MRI Interventions is creating innovative platforms for performing the next generation of minimally invasive surgical procedures in the brain and heart. The company's ClearPoint® system utilizes a hospital's existing diagnostic or intraoperative MRI scanner to enable a range of minimally invasive procedures in the brain. In partnership with Siemens Healthcare, MRI Interventions is developing the ClearTrace® system to enable MRI-guided catheter ablations to treat cardiac arrhythmias, including atrial fibrillation. For more information, please visit www.mriinterventions.com.
CONTACT: MRI Interventions, Inc.
David Carlson, CFO, 901-522-9300
Released October 8, 2014